These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9626119)

  • 1. A defect in renal calcium conservation may contribute to the pathogenesis of postmenopausal osteoporosis.
    Heshmati HM; Khosla S; Burritt MF; O'Fallon WM; Riggs BL
    J Clin Endocrinol Metab; 1998 Jun; 83(6):1916-20. PubMed ID: 9626119
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of renal calcium conservation with estrogen replacement therapy in women in early postmenopause--a clinical research center study.
    McKane WR; Khosla S; Burritt MF; Kao PC; Wilson DM; Ory SJ; Riggs BL
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3458-64. PubMed ID: 8530583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormalities in circadian patterns of bone resorption and renal calcium conservation in type I osteoporosis.
    Eastell R; Calvo MS; Burritt MF; Offord KP; Russell RG; Riggs BL
    J Clin Endocrinol Metab; 1992 Mar; 74(3):487-94. PubMed ID: 1740481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of endogenous estrogen on renal calcium and phosphate handling in elderly women.
    Dick IM; Devine A; Beilby J; Prince RL
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E430-5. PubMed ID: 15466921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of growth hormone administration on bone mineral metabolism, PTH sensitivity and PTH secretory rhythm in postmenopausal women with established osteoporosis.
    Joseph F; Ahmad AM; Ul-Haq M; Durham BH; Whittingham P; Fraser WD; Vora JP
    J Bone Miner Res; 2008 May; 23(5):721-9. PubMed ID: 18052753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal osteoporosis as a manifestation of renal hypercalciuria with secondary hyperparathyroidism.
    Sakhaee K; Nicar MJ; Glass K; Pak CY
    J Clin Endocrinol Metab; 1985 Aug; 61(2):368-73. PubMed ID: 4008611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses.
    Nordin BE; Need AG; Morris HA; Horowitz M
    Osteoporos Int; 1999; 9(4):351-7. PubMed ID: 10550453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone responsiveness to parathyroid hormone in normal and osteoporotic postmenopausal women.
    Tsai KS; Ebeling PR; Riggs BL
    J Clin Endocrinol Metab; 1989 Nov; 69(5):1024-7. PubMed ID: 2793989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response of the parathyroid gland to infusion of human parathyroid hormone-(1-34) [PTH-(1-34)]: demonstration of suppression of endogenous secretion using immunoradiometric intact PTH-(1-84) assay.
    Cosman F; Shen V; Herrington B; Lindsay R
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1345-51. PubMed ID: 1955517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is skeletal responsiveness to thyroid hormone altered in primary osteoporosis or following estrogen replacement therapy?
    Langdahl BL; Loft AG; Møller N; Weeke J; Eriksen EF; Mosekilde L; Charles P
    J Bone Miner Res; 1997 Jan; 12(1):78-88. PubMed ID: 9240729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical effects of a calcium supplement in postmenopausal women with primary hyperparathyroidism.
    Horowitz M; Wishart JM; Need AG; Morris HA; Nordin BE
    Horm Metab Res; 1994 Jan; 26(1):39-42. PubMed ID: 8150422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.
    Lips P; Duong T; Oleksik A; Black D; Cummings S; Cox D; Nickelsen T
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1212-21. PubMed ID: 11238511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.
    Deal C; Omizo M; Schwartz EN; Eriksen EF; Cantor P; Wang J; Glass EV; Myers SL; Krege JH
    J Bone Miner Res; 2005 Nov; 20(11):1905-11. PubMed ID: 16234962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Increase of PTH in post-menopausal osteoporosis].
    Cerdà D; Peris P; Monegal A; Albaladejo C; Martínez de Osaba MJ; Surís X; Guañabens N
    Rev Clin Esp; 2011; 211(7):338-43. PubMed ID: 21596374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of gonadal steroid suppression on skeletal sensitivity to parathyroid hormone in men.
    Leder BZ; Smith MR; Fallon MA; Lee ML; Finkelstein JS
    J Clin Endocrinol Metab; 2001 Feb; 86(2):511-6. PubMed ID: 11158001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chronic liver disease on bone mineral density and bone metabolism markers in postmenopausal women.
    Uretmen S; Gol M; Cimrin D; Irmak E
    Eur J Obstet Gynecol Reprod Biol; 2005 Nov; 123(1):67-71. PubMed ID: 16051419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal leak of calcium in post-menopausal osteoporosis.
    Nordin BE; Horowitz M; Need A; Morris HA
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):41-5. PubMed ID: 8050130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parathyroid function in relation to intestinal function and renal calcium reabsorption in patients with nephrolithiasis.
    Lindsjö M; Danielson BG; Fellström B; Norheim I; Wide L; Ljunghall S
    Scand J Urol Nephrol; 1992; 26(1):55-64. PubMed ID: 1631508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women.
    Heshmati HM; Riggs BL; Burritt MF; McAlister CA; Wollan PC; Khosla S
    J Clin Endocrinol Metab; 1998 Mar; 83(3):751-6. PubMed ID: 9506720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.